Women Researcher Award
Maria De Nazaré Correia Soeiro
Fiocruz, Brazil
Maria De Nazaré Correia Soeiro is a researcher affiliated with Fiocruz in Brazil whose scholarly profile is centered on parasitology, infectious disease research, and the discovery and characterization of therapeutic candidates against kinetoplastid parasites. Her publication record includes investigations of Trypanosoma cruzi and Leishmania species, experimental pharmacology, medicinal chemistry, natural products, molecular approaches, and drug-discovery strategies. The available bibliometric profile reports 123 indexed documents, 3,225 citations, and an h-index of 31, providing a quantitative basis for consideration within a women researcher recognition program.
Abstract
This academic recognition profile presents the research record of Maria De Nazaré Correia Soeiro of Fiocruz, Brazil, in the field of parasitology. Her documented research encompasses therapeutic discovery and pharmacological evaluation directed toward parasitic diseases, particularly Chagas disease and leishmaniasis. Recent publications address anti-trypanosomatid activity of natural-product extracts, imatinib-derived compounds against Trypanosoma cruzi, probiotic interactions with parasite infection models, and molecular or phenotypic approaches to antileishmanial drug development. [1] [2] The reported Scopus metrics of 123 documents, 3,225 citations, and an h-index of 31 indicate a sustained scholarly contribution and provide bibliometric context for consideration for the Women Researcher Award. [3]
Keywords
Maria De Nazaré Correia Soeiro; Women Researcher Award; parasitology; Fiocruz; Chagas disease; Trypanosoma cruzi; leishmaniasis; Leishmania; antiparasitic drug discovery; medicinal chemistry; pharmacology; natural products; infectious diseases; molecular parasitology; Brazil.
Introduction
Parasitic diseases remain important subjects of biomedical research because effective treatment can be limited by parasite biology, drug toxicity, resistance, pharmacokinetic constraints, and the relatively small number of therapeutic options available for some neglected infections. Within this context, research combining parasitology, pharmacology, medicinal chemistry, and experimental infection models can contribute to the identification and prioritization of candidate interventions. Soeiro’s publication record reflects this interdisciplinary approach, with studies addressing both established and emerging chemical strategies for antiparasitic development. [4] [5]
Research Profile
The available profile identifies Maria De Nazaré Correia Soeiro with Fiocruz in Brazil and places her principal subject area within parasitology. Her documented publication portfolio is particularly associated with kinetoplastid parasites and therapeutic research. Bibliometric information supplied for this profile records 123 documents, 3,225 citations, and an h-index of 31. [3]
- Parasitology and infectious disease research.
- Antiparasitic drug discovery and candidate evaluation.
- Research on Trypanosoma cruzi and Chagas disease.
- Research on Leishmania species and antileishmanial strategies.
- Pharmacological characterization of bioactive compounds and natural products.
- Molecular and computational approaches supporting parasite-targeted research.
Research Contributions
A significant component of the documented work concerns the search for improved therapeutic approaches against trypanosomatid parasites. The 2026 study on crude extracts of Chromolaena hookeriana and Campuloclinium macrocephalum examines in vitro anti-trypanosomatid activity alongside chemical profiling, illustrating the use of botanical resources as a source of potentially bioactive compounds. [1]
Another recent publication investigates the activity, selectivity, and pharmacological profile of imatinib derivatives against Trypanosoma cruzi. This work represents a drug-repurposing and medicinal-chemistry-oriented strategy in which derivatives of a known pharmacological scaffold are evaluated for antiparasitic potential. [2]
Publications
Selected publications associated with Maria De Nazaré Correia Soeiro demonstrate a sustained focus on parasitic disease research and therapeutic discovery. The following list highlights recent and representative works supplied for this recognition profile.
- Almeida Fiuza, L. F., et al., including Maria de Nazaré Correia Soeiro. In vitro anti-Trypanosomatid activity and chemical profile of crude extracts of Chromolaena hookeriana and Campuloclinium macrocephalum (Asteraceae). Memórias do Instituto Oswaldo Cruz, 2026.[1]
- Nesic de Freitas, L., et al., including Maria de Nazaré Correia Soeiro. The activity, selectivity and pharmacological profile of imatinib derivates against Trypanosoma cruzi. Parasitology, 2026.[2]
Research Impact
The supplied bibliometric record reports 3,225 citations and an h-index of 31 across 123 documents. These measures provide evidence of a substantial citation footprint within the indexed scholarly record, although bibliometric indicators should be interpreted alongside publication quality, research originality, collaboration, methodological contribution, and broader scientific influence. [3]
Award Suitability
Based on the information supplied, Maria De Nazaré Correia Soeiro presents a research profile relevant to the Women Researcher Award within the International Popular Scientist Awards. The principal considerations include a sustained publication record in parasitology, documented research addressing neglected and infectious diseases, contributions to antiparasitic drug discovery, and a reported citation and h-index profile. The publication record further demonstrates engagement with collaborative and interdisciplinary research involving pharmacology, medicinal chemistry, molecular biology, natural products, and experimental parasitology.
Conclusion
Maria De Nazaré Correia Soeiro’s documented research profile is characterized by sustained contributions to parasitology and antiparasitic drug discovery at Fiocruz, Brazil. Her publications address important areas including Trypanosoma cruzi, Leishmania, experimental infection, pharmacological evaluation, natural products, molecular docking, and candidate therapeutic compounds. With 123 reported documents, 3,225 citations, and an h-index of 31, the supplied bibliometric record provides substantial quantitative context for her scholarly activity. [3] The combination of research continuity, interdisciplinary methods, and relevance to neglected parasitic diseases makes her profile appropriate for consideration under a Women Researcher Award category, subject to formal verification and award-specific evaluation.
External Links
References
- Almeida Fiuza, L. F., et al. (2026). In vitro anti-Trypanosomatid activity and chemical profile of crude extracts of Chromolaena hookeriana and Campuloclinium macrocephalum (Asteraceae). Memórias do Instituto Oswaldo Cruz.
https://doi.org/10.1590/0074-02760250296
- Nesic de Freitas, L., et al. (2026). The activity, selectivity and pharmacological profile of imatinib derivates against Trypanosoma cruzi. Parasitology.
https://doi.org/10.1017/S0031182026101887
- Elsevier. (n.d.). Scopus author details: Maria De Nazaré Correia Soeiro, Author ID 6701501560. Scopus.
https://www.scopus.com/pages/authors/6701501560
- Soeiro, M. N. C. (2022). Perspectives for a new drug candidate for Chagas disease therapy. Memórias do Instituto Oswaldo Cruz.
https://doi.org/10.1590/0074-02760220004
- Silva da Gama, A. N., & Soeiro, M. N. C. (2021). Quinoline-based Compounds as Key Candidates to Tackle Drug Discovery Programs of Microbicidal Agents. Current Pharmaceutical Design.
https://doi.org/10.2174/1381612826666201006125644